GPT and metabolic dysfunction-associated steatohepatitis: In a preliminary report on six patients with NASH, 10 mg/day of rosuvastatin for 12 months not only showed improvement in AST and ALT levels, but also the complete resolution of ultrasonographic findings of NASH in five patients [16].